The global Infectious Diseases Diagnostics Market is expected to grow at a CAGR of 5.9% from 2018 to 2025 to reach $23.4 billion by 2025.

The growth of this market will be driven by factors such as increasing global prevalence of infectious diseases, growing awareness for early detection using specific diagnostic tests, growth in funding for research on infectious disease diagnostics, and shift in focus from centralized laboratories to decentralized point-of-care testing. However, lack of unfavorable and inadequate reimbursement scenario may hamper the growth of this market to a certain extent.

Browse in depth report: https://www.meticulousresearch.com/product/infectious-disease-diagnostics-market-4976/

Immunodiagnostics accounted for the largest share of the infectious disease diagnostics market in 2018. This is owing to the increasing use of immunoassays in POC infectious disease testing, development of novel tests, rising trend of automation, increasing awareness about health and fitness, and reduced complications associated with the instruments. Immunodiagnostic technologies are majorly used for the detection of infectious diseases. Radioimmunoassay and Enzyme Linked Immunosorbent Assay (ELISA) were the predominant techniques used for the diagnosis. Lower complexity, high-sensitivity, and its ease of use are the major factors contributed to the growth of the immunodiagnostic technology for the diagnosis of infectious diseases. However, polymerase chain reaction (PCR) segment is expected to grow significantly during the forecast period. Increasing adoption of the molecular diagnostic technology in place of antigen testing by immunoassays, increasing chances of detecting minute amount of protein biomarkers with high specificity; and growing probability of detecting infectious diseases to mitigate the result with high accuracy is expected to drive the growth of the molecular diagnostic technology in the infectious disease diagnostics market.

This research report analyzes major geographies and provides comprehensive analysis of North America (U.S., Canada), Europe (Germany, France, and U.K.), Asia-Pacific (China, and Japan), Latin America, and Middle East & Africa. North America commanded the largest share of the global infectious disease diagnostics market in 2017, followed by Europe and Asia Pacific. The highest share of North American region in the infectious disease diagnostics market is primarily attributed to the growing healthcare sector, increasing need to treat various infectious diseases, increasing healthcare expenditure, growing demand of point-of-care testing, increase in the research and development coupled with the development of novel advanced technologies for diagnosis, and large number of patient population.
Asia Pacific region is expected to be the fastest growing geographic market for infectious disease diagnostics market with countries, such as China, Japan, India and Singapore among others are being the largest contributors to the growth of the market. Additionally, rapid urbanization, increasing investments by healthcare providers towards infrastructure improvement, need to manage growing burden of infectious diseases, and government efforts to improve accessibility of diagnostic services are expected to equally influence the overall growth of the infectious disease diagnostics market during the forecast period.

Request sample report on : https://www.meticulousresearch.com/request-sample-report/cp_id=4976

Key Players
The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2016-2019). The key players profiled in the global infectious disease diagnostics market research report are Abbott Laboratories (US), Danaher (US), Bio-Rad Laboratories (US), bioMérieux SA (France), F. Hoffmann-La Roche Ltd (Switzerland), BD (US), DiaSorin S.p.A. (Italy), Meridian Bioscience, Inc. (US), Quidel Corporation (US), and Thermo Fisher Scientific Inc. (US) among others.

Contact Info:
Khushal
Email: [email protected]
Contact Sales- +1-646-781-8004